Anúncio
Anúncio
IDYA
IDEAYA Biosciences, Inc. Common Stock
33.85
USDPatrocinado
-0.72
-2.07%
02 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
33.91
+0.06
+0.18%
Relatórios de Lucros IDYA
Rácio de surpresa positiva
IDYA separação 11 de 26 últimas estimativas.
42%
Próximo Relatório
Data do Próximo Relatório
11 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$6.37M
/-$0.96
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-96.94%
/-172.18%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-9.06%
/-35.57%
IDEAYA Biosciences, Inc. Common Stock earnings per share and revenue
On 04 de nov. de 2025, IDYA reported earnings of 1.33 USD per share (EPS) for Q3 25, beating the estimate of -0.55 USD, resulting in a 339.34% surprise. Revenue reached 207.83 milhão, compared to an expected 5.12 milhão, with a 3958.80% difference. The market reacted with a -2.81% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 20 analistas forecast an EPS of -0.96 USD, with revenue projected to reach 6.37 milhão USD, implying an diminuir of -172.18% EPS, and diminuir of -96.94% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
19 de dez. de 2025 Para Q4 25
Estimativa
-$0.25
Real
-$0.19
Surpresa
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were IDEAYA Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, IDEAYA Biosciences, Inc. Common Stock reported EPS of $1.33, beating estimates by 339.34%, and revenue of $207.83M, 3958.8% above expectations.
How did the market react to IDEAYA Biosciences, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -2.81%, changed from $31.36 before the earnings release to $30.48 the day after.
When is IDEAYA Biosciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for 11 de fev. de 2026.
What are the forecasts for IDEAYA Biosciences, Inc. Common Stock's next earnings report?
Based on 20
analistas, IDEAYA Biosciences, Inc. Common Stock is expected to report EPS of -$0.96 and revenue of $6.37M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio